Carson Wealth (CWM LLC)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-225
Closed -$9K 5279
2024
Q2
$9K Buy
225
+21
+10% +$875 ﹤0.01% 3641
2024
Q1
$9K Buy
204
+2
+1% +$84 ﹤0.01% 3430
2023
Q4
$9K Sell
202
-151
-43% -$4.34K ﹤0.01% 3264
2023
Q3
$8K Buy
353
+329
+1,371% +$8.23K ﹤0.01% 3280
2023
Q2
$1K Sell
24
-11
-31% -$338 ﹤0.01% 4119
2023
Q1
$1K Buy
35
+10
+40% +$293 ﹤0.01% 3981
2022
Q4
$1K Hold
25
﹤0.01% 3903
2022
Q3
$1K Hold
25
﹤0.01% 3827
2022
Q2
$1K Buy
25
+12
+92% +$341 ﹤0.01% 3701
2022
Q1
$0 Buy
+13
New +$380 ﹤0.01% 3940

Other funds holding CERE

Carson Wealth (CWM LLC)'s CERE Position: Q3 2024 in Review

Carson Wealth (CWM LLC) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 225 shares — an estimated $9K sold.

Carson Wealth (CWM LLC) first reported a position in CERE in Q1 2022 and held it in 10 quarters. The position peaked at $9K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Carson Wealth (CWM LLC) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 225 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $9K.
  • Carson Wealth (CWM LLC) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
  • Carson Wealth (CWM LLC)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $9K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2024, filed 8 Oct 2024.